Patil Neena M 4
4 · Jazz Pharmaceuticals plc · Filed Jun 1, 2026
Research Summary
AI-generated summary of this filing
Jazz Pharmaceuticals (JAZZ) EVP & Chief Legal Officer Neena Patil Sells Shares
What Happened
Neena M. Patil, Executive Vice President and Chief Legal Officer of Jazz Pharmaceuticals (JAZZ), disposed of 1,192 shares in an open-market sale on May 28, 2026 at $236.97 per share, for a total of $282,468. This was a sale (not a purchase) and, per the filing, was executed automatically under a pre-established plan.
Key Details
- Transaction date and price: 2026-05-28 at $236.97 per share.
- Total value: $282,468.
- Transaction type: Sale (Form 4 code S).
- Plan/footnote: Executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 26, 2026; the transaction occurred automatically and was not discretionary (Footnote F1).
- Shares owned after transaction: Not disclosed in the provided filing.
- Filing timeliness: Report filed 2026-06-01 — appears timely (within the two business-day Form 4 filing window).
Context
Sales by executives can be routine (for diversification, liquidity, tax reasons, or via pre-set plans) and do not, by themselves, indicate a change in company outlook. Because this sale was made under a 10b5-1 plan and was automatic, it likely reflects a pre-arranged disposition schedule rather than a discretionary trade by the insider.
Insider Transaction Report
- Sale
Ordinary Shares
[F1]2026-05-28$236.97/sh−1,192$282,468→ 52,626 total
Footnotes (1)
- [F1]This transaction was made pursuant to a plan adopted by the reporting person on February 26, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.